Free Trial
→ [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (From Crypto Swap Profits) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 7 of 15

Slide 7
Back to 6
Continue to 8
 
Back to 6
Continue to 8
 

Revolution Medicines (NASDAQ:RVMD)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
12 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$61.00 (10.6% Upside)

About Revolution Medicines

Revolution Medicines logoRevolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/7/2024HC WainwrightBoost Price TargetBuy ➝ Buy$62.00 ➝ $64.00
11/7/2024Needham & Company LLCBoost Price TargetBuy ➝ Buy$61.00 ➝ $68.00
11/7/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$54.00 ➝ $63.00
11/7/2024Piper SandlerBoost Price TargetOverweight ➝ Overweight$57.00 ➝ $70.00
10/28/2024GuggenheimBoost Price TargetBuy ➝ Buy$72.00 ➝ $82.00
10/28/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$55.00 ➝ $60.00
10/24/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$61.00 ➝ $61.00
10/7/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$61.00 ➝ $61.00
9/27/2024BarclaysBoost Price TargetOverweight ➝ Overweight$54.00 ➝ $60.00
8/12/2024HC WainwrightReiterated RatingBuy ➝ Buy$56.00 ➝ $56.00
Slide 7
Back to 6
Continue to 8
 

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

More From MarketBeat
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
20 High-Yield Dividend Stocks that Could Ruin Your Retirement
Almost everyone loves a company that pays strong dividends. Who doesn't like receiving a check every quarter f...
MarketBeat
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
10 Best Small Cap Stocks to Buy Now
Let's talk about small cap stocks. It's common knowledge that tilting your stock portfolio toward smaller-capi...
MarketBeat
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
7 Stocks Under $50 to Buy at 52-Week Lows
In this special presentation, we're offering you seven stocks that meet two criteria important to investors in...
MarketBeat